Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 802 results for "Ibrutinib"

Imbruvica gains breakthrough status for treating chronic lymphocytic leukemia
Examiner.com

Imbruvica gains breakthrough status for treating chronic lymph...

The FDA has expanded the use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), and thus have shown poor responses to standard treatment for the disease. The news ... Examiner.com, 1 month ago
FDA Expands Use of Imbruvica for Form of Leukemia US News & World Report, 1 month ago
[x]  

6 images for Ibrutinib

SearchBug, 1 month ago
Drug Discovery and Development, 1 month ago
Ecancer Medicalscience, 1 month ago
Examiner.com, 1 month ago
OncLive, 1 month ago
Scottrade, 1 month ago
Ecancer Medicalscience

Genetic mutation linked to acquired ibrutinib resistance in MCL

A relapse-specific BTK genetic mutation identified in patients with mantle cell lymphoma may serve as a target to overcome both primary and acquired ibrutinib resistance, according to results of a longitudinal study. Prior studies have found ...
 Orthopedics Today2 weeks ago A Solution to Ibrutinib Resistance in MCL?  American Journal of Public Health3 weeks ago ONLINE FIRST: MCL--Study Identifies Rational Drug Combinations that May Overcome Resistance to Ibrutinib  Oncology Times3 weeks ago Study identifies rational drug combinations that may overcome mantle cell lymphoma resistance to ibrutinib  Ecancer Medicalscience1 month ago
[x]  
Pharma Letter

RESONATE STUDY: CLL/SLL Survival Improved with Ibrutinib

Volume 23 Issue Number 8 August 2014 ISSN 1059380 Patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who experience short response duration, who are 65 years or older or who have adverse cytogenetics (i.e., ...
 CancerWatch1 week ago 8/11/14 - IMBRUVICA® ibrutinib Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia CLL and CLL patients with del 17p  Pharmacy Choice3 weeks ago IMBRUVICA® ibrutinib Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia CLL and CLL patients with del 17p  HispanicBusiness.com3 weeks ago European Medicines Agency EMA Issues Positive Opinion, Recommends Full Approval of IMBRUVICA ibrutinib for Treatment of Two Blood Cancers  Pharmacy Choice4 weeks ago
[x]  

Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval

The EU approval of Pharmacyclics ( PCYC ) and partner Johnson & Johnson's ( JNJ ) oncology drug Imbruvica (ibrutinib) appears well on track with the European Medicines Agency's ( EMA.TO ) Committee for Medicinal Products for Human Use ( CHMP ) ...
 Yahoo! Finance1 month ago FDA expands approval for Johnson & Johnson, Pharmacyclics' Imbruvica in CLL  FirstWord Pharma1 month ago
[x]  

EMA recomienda la aprobación de IMBRUVICA para el tratamiento de dos cánceres sanguíneos

-- La Agencia Europea del Medicamento(EMA) emite una opinión positiva, recomendando la aprobación de IMBRUVICA (ibrutinib) para el tratamiento de dos cánceres sanguíneos SUNNYVALE, California , 26 de julio de 2014 /PRNewswire/ ...
 PR Newswire1 month ago
Pharmaceutical Business Review

Pending EC decision: Imbruvica, Ibrutinib, Opinion date: 24-Jul-2014

the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Imbruvica 140 mg hard capsule intended for the treatment of relapsed or refractory ...
 European Medicines Agency1 month ago European Medicines Agency recommends approval of two new treatment options for rare cancers  Bionity.com4 weeks ago CHMP recommends Pharmacyclics Imbruvica to treat two blood cancers  Pharmaceutical Technology1 month ago EMA's CHMP backs approval of two new treatment options for rare cancers26-07-2014  Pharma Letter1 month ago
[x]  

Ibrutinib and Idelalisib Coming to Europe Soon

Two novel targeted agents that look to change the whole paradigm of treatment for chronic lymphocytic leukemia (CLL) look like they will be available in Europe soon. Ibrutinib ( Imbruvica , Janssen) and idelalisib ( Zydelig , Gilead) have both ...
 Diabetes Care1 month ago Treatment for CLL: Change Aplenty, More Coming  Medscape1 month ago

Pharmacyclics : Special Notice - 65-- Imbruvica (Ibrutinib)

Notice Type: Special Notice Posted Date: 31-JUL-14 Office Address: Department of Veterans Affairs ;SAO West NCO 18 El Paso;Carlos Jaquez, Contracting Officer; 11495 Turner Road ;El Paso TX 79936-1372 Subject: 65-- Imbruvica (Ibrutinib) ...
 4 Traders1 month ago

J&J, Pharmacyclics celebrate yet another nod for leukemia med Imbruvica

Johnson & Johnson's ($JNJ) new blood cancer drug Imbruvica (ibrutinib) is on a roll. The FDA just armed the drug with a new indication in chronic lymphocytic leukemia, adding to a series of regulatory nods. The new use--in patients with a rare ...
 FiercePharma1 month ago JJ Pharmacyclics celebrate yet another nod for leukemia med Imbruvica  Big News Network1 month ago

B-Cell Non-Hodgkin's Lymphoma Treatment Market Value to Reach $5.4 Billion by 2018, Reveals New Report

Market Research Reports, Inc. has announced the addition of OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 research report to their website http://www.marketresearchreports.com Lewes, DE -- ...
 Digital Journal3 hours ago Market Research Reports, Inc. (www.marketresearchreports.com): B-cell Non-Hodgkin's Lymphoma Treatment Market Value to Reach $5.4 Billion by 2018, Reveals New Report  BusinessWeek1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less